NCT00092118

The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 1,992 (actual)
• Sponsor: Organon and Co · Industry
• Sex: All
• Age: 15 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the effect of an approved medication on the symptoms of perennial allergic rhinitis (an inflammation of the mucous membrane of the nose similar to that found in hay fever except that symptoms persist throughout the year), in patients who have a history of perennial allergic rhinitis.

Conditions

• Rhinitis, Allergic, Perennial

Interventions

Type	Name	Description
DRUG	Montelukast	one 10 mg tablet, taken once daily at bed time for 6 weeks
DRUG	Comparator: Placebo	one placebo tablet, taken once daily at bed time for 6 weeks

Timeline

• Start date: 2003-10-01
• Primary completion: 2004-05-01
• Completion: 2004-05-01
• First posted: 2004-09-24
• Last updated: 2022-02-03
• Results posted: 2010-07-23